advertisement

---

Olvera-Montaño O 1

Showing records 1 to 1 | Display all abstracts from Olvera-Montaño O

76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Gómez-Aguayo F; Paczka JA; Leñero-Córdova R; Jiménez-Román J; Davila-Villarreal J; Hartleben C; Baiza-Durán L; Olvera-Montaño O; García-Velez F; Muñoz-Villegas P
Ophthalmology and therapy 2018; 7: 145-156

---